Protein Design Labs, Inc. Announces Webcast Of Presentation At 24th Annual JPMorgan Healthcare Conference

FREMONT, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDL) today announced that it will make available a live webcast of its presentation at the 24th Annual JPMorgan Healthcare Conference in San Francisco. The live webcast will begin at 8:30 a.m. Pacific time (11:30 a.m. Eastern time) on January 11, 2006. The presentation will be conducted by Mr. Mark McDade, Chief Executive Officer, and Dr. Steven Benner, Senior Vice President and Chief Medical Officer. The live audio webcast of the presentation will be available to all interested parties at PDL's website, www.pdl.com, or may be directly accessed by the following link, http://equityconferences.jpmorgan.com . A replay will be available via both websites starting approximately 24 hours after the live presentation.

PDL is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. Further information on PDL is available at www.pdl.com.

NOTE: Protein Design Labs and the PDL logo are registered U.S. trademarks of Protein Design Labs, Inc.

CONTACT: James R. Goff, Senior Director, Investor Relations of ProteinDesign Labs, Inc., +1-510-574-1421, or jgoff@pdl.com

Web site: http://www.pdl.com/